AI Mania Drives BubbleLike Concentration in SP 500 Analysts Warn Goldman Sachs Maintains Positive Outlook on LATAM Airlines Adjusts Price Target Inflations Broadening Beyond Oil and Iran These Sectors Show Reaccelerating Price Pressures Scams Surge in Sophistication Global Fightback Gains Momentum Apple Positioned to Lead Emerging Agentic AI Smartphone Market BofA Suggests Golden Dome Missile Defense Concept Poses Critical Test for Defense Contractors MNST Q1 2026 Earnings EPS Beats Estimates as Company Delivers Strong Profitability CPS Q1 2026 Earnings Earnings Miss Estimates Significantly as EPS Falls Short RLI Q1 2026 Earnings EPS Beats by Nearly 5 as Underwriting Disciplines Deliver China Pharma Holdings CPHI Q3 2011 Earnings EPS Miss Weighs on Sentiment EPAM Q1 2026 Earnings EPS Surpasses Estimates Amid Revenue Opacity Limoneira LMNR Q1 2026 Earnings EPS Misses Estimates Amid Operational Pressures Stock Eases Creative Global Technology Holdings Limited CGTL Slips 6 as Stock Tests Key Support Levels OKYO Pharma OKYO Edges Higher on Modest Gains Holds Above Key Support Adamas Trust Series G Preferred ADAMZ Slips Modestly Holds Near Support Levels Target Hospitality Corp TH Rallies 251 Approaches Key Resistance Level Danaos Corporation DAC Holds Steady Near Support as Shipping Sector Faces Headwinds Invest Green Acquisition Corporation Units IGACU Dips 157 as It Tests Support Near 956 Trainline Raises FullYear Guidance for Second Time in 2026 TBHC Q1 2026 Earnings EPS Misses Expectations as Loss Widens GigCapital8 Rights GIWWR Holds Steady at 032 Tight Range Signals Stalemate EVO Q1 2026 Earnings Shares Rise Despite Significant EPS Miss ClearSign Technologies CLIR Q1 2026 Earnings WiderThanExpected Loss Stalls Recovery Hopes Prelude Therapeutics Q1 2026 Earnings Significant EPS Beat Amid No Revenue MDGL Q1 2026 Earnings Narrowed Loss Beats Expectations as Rezdiffra Launch Progresses FITBI Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency AFGE Q1 2026 Earnings EPS Misses Estimates Amid Stable Bond Performance ELVN Q1 2026 Earnings NarrowerthanExpected Loss as PreRevenue Biotech Advances Pipeline